← FDA Drug Approvals (Drugs@FDA)

TRIAMTERENE AND HYDROCHLOROTHIAZIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 1996-06-07

Drug application

FDA Application #
ANDA074701
Application type
Abbreviated New Drug Application (Generic)
Brand name
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
Generic name
Hydrochlorothiazide
Active ingredients
HYDROCHLOROTHIAZIDE; TRIAMTERENE
Dosage form
CAPSULE
Route
ORAL
Marketing status
Discontinued
Sponsor
PHARMOBEDIENT
First approval
1996-06-07

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown